BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 1671391)

  • 1. Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor.
    Vogelmeier C; Hubbard RC; Fells GA; Schnebli HP; Thompson RC; Fritz H; Crystal RG
    J Clin Invest; 1991 Feb; 87(2):482-8. PubMed ID: 1671391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor.
    McElvaney NG; Nakamura H; Birrer P; Hébert CA; Wong WL; Alphonso M; Baker JB; Catalano MA; Crystal RG
    J Clin Invest; 1992 Oct; 90(4):1296-301. PubMed ID: 1357002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of recombinant secretory leukoprotease inhibitor aerosolized to normals and individuals with cystic fibrosis.
    McElvaney NG; Doujaiji B; Moan MJ; Burnham MR; Wu MC; Crystal RG
    Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):1056-60. PubMed ID: 8105734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous recombinant secretory leukoprotease inhibitor augments antineutrophil elastase defense.
    Birrer P; McElvaney NG; Gillissen A; Hoyt RF; Bloedow DC; Hubbard RC; Crystal RG
    J Appl Physiol (1985); 1992 Jul; 73(1):317-23. PubMed ID: 1354669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant secretory leukoprotease inhibitor augments glutathione levels in lung epithelial lining fluid.
    Gillissen A; Birrer P; McElvaney NG; Buhl R; Vogelmeier C; Hoyt RF; Hubbard RC; Crystal RG
    J Appl Physiol (1985); 1993 Aug; 75(2):825-32. PubMed ID: 7901193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aerosolization of recombinant SLPI to augment antineutrophil elastase protection of pulmonary epithelium.
    Vogelmeier C; Buhl R; Hoyt RF; Wilson E; Fells GA; Hubbard RC; Schnebli HP; Thompson RC; Crystal RG
    J Appl Physiol (1985); 1990 Nov; 69(5):1843-8. PubMed ID: 2272977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis.
    Birrer P; McElvaney NG; Rüdeberg A; Sommer CW; Liechti-Gallati S; Kraemer R; Hubbard R; Crystal RG
    Am J Respir Crit Care Med; 1994 Jul; 150(1):207-13. PubMed ID: 7912987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase.
    van Wetering S; van der Linden AC; van Sterkenburg MA; Rabe KF; Schalkwijk J; Hiemstra PS
    J Investig Med; 2000 Sep; 48(5):359-66. PubMed ID: 10979241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of secretory leukocyte protease inhibitor (SLPI) in bronchial secretions from patients with hypersecretory respiratory diseases.
    Kouchi I; Yasuoka S; Ueda Y; Ogura T
    Tokushima J Exp Med; 1993 Jun; 40(1-2):95-107. PubMed ID: 8105562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of secretory leukoprotease inhibitor to augment lung antineutrophil elastase activity.
    Vogelmeier C; Gillissen A; Buhl R
    Chest; 1996 Dec; 110(6 Suppl):261S-266S. PubMed ID: 8989162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of secretory leukoprotease inhibitor gene expression in human bronchial epithelial cells by phorbol ester.
    Maruyama M; Hay JG; Yoshimura K; Chu CS; Crystal RG
    J Clin Invest; 1994 Jul; 94(1):368-75. PubMed ID: 7913712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of native and oxidation-resistant secretory leukoprotease inhibitor on cystic fibrosis sputum: inhibition of neutrophil elastase activity and of sputum-induced secretion from porcine tracheal submucosal glands.
    Schuster A; Hansen G; Zubrod-Eichert C; Wahn V
    Pediatr Res; 1996 Nov; 40(5):732-7. PubMed ID: 8910939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of lung diseases with antiproteases].
    Vogelmeier C; Buhl R
    Pneumologie; 1994 Feb; 48(2):57-62. PubMed ID: 7910401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the secretory leukoprotease inhibitor gene in epithelial cells.
    Abe T; Kobayashi N; Yoshimura K; Trapnell BC; Kim H; Hubbard RC; Brewer MT; Thompson RC; Crystal RG
    J Clin Invest; 1991 Jun; 87(6):2207-15. PubMed ID: 1674946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory effects of endogenous protease inhibitors in acute lung inflammatory injury.
    Gipson TS; Bless NM; Shanley TP; Crouch LD; Bleavins MR; Younkin EM; Sarma V; Gibbs DF; Tefera W; McConnell PC; Mueller WT; Johnson KJ; Ward PA
    J Immunol; 1999 Mar; 162(6):3653-62. PubMed ID: 10092827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretory leukocyte protease inhibitor and its potential interactions with elastase and cathepsin B in gingival crevicular fluid and saliva from patients with chronic periodontitis.
    Cox SW; Rodriguez-Gonzalez EM; Booth V; Eley BM
    J Periodontal Res; 2006 Oct; 41(5):477-85. PubMed ID: 16953825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes.
    Sallenave JM; Shulmann J; Crossley J; Jordana M; Gauldie J
    Am J Respir Cell Mol Biol; 1994 Dec; 11(6):733-41. PubMed ID: 7946401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local impairment of anti-neutrophil elastase capacity in community-acquired pneumonia.
    Greene C; Taggart C; Lowe G; Gallagher P; McElvaney N; O'Neill S
    J Infect Dis; 2003 Sep; 188(5):769-76. PubMed ID: 12934194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchiolitis obliterans syndrome after (heart-)lung transplantation. Impaired antiprotease defense and increased oxidant activity.
    Hirsch J; Elssner A; Mazur G; Maier KL; Bittmann I; Behr J; Schwaiblmair M; Reichenspurner H; Fürst H; Briegel J; Vogelmeier C
    Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1640-6. PubMed ID: 10556134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of secretory leukocyte proteinase inhibitor to the antiprotease defense system of the peripheral lung: effect of ozone-induced acute inflammation.
    Nadziejko C; Finkelstein I; Balmes JR
    Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1592-8. PubMed ID: 7582300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.